4th Quarter - Report
SIMS STRATEGIES, LLC for AMAG PHARMACEUTICAL
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical issues related to womens health product access.
Foreign entity interest: COVIS PHRMA GmbH, identified on Line 27, holds the intellectual property underlying AMAG Pharmaceuticals work and would benefit from AMAGs success ensuring public access to its product.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD PRETTYMAN | Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE) |
| MICHAELA SIMS | Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COVIS PHRMA GMBH | Switzerland | Switzerland | — | — |
| COVIS TOPCO S.A R.L. | Luxembourg | Luxembourg | 100.0% | — |
| APOLLO OVERSEAS PARTNERS (892 AIV) IX, L.P. | Cayman Islands | Cayman Islands | 23.5% | — |
| COVIS MIDCO 2 S.A R.L. | Luxembourg | Luxembourg | 100.0% | — |
| COVIS EQUITYCO SCA | Luxembourg | Luxembourg | 100.0% | — |
| COVIS FINCO S.A R.L. | Luxembourg | Luxembourg | 100.0% | — |
| AP IX (EURO AIV), L.P. | Cayman Islands | Cayman Islands | 42.1% | — |
| COVIS HOLDCO S.A R.L. | Luxembourg | Luxembourg | 100.0% | — |
| COVIS MIDCO 1 S.A R.L. | Luxembourg | Luxembourg | 100.0% | — |
| COVIS GROUP S.A R.L. | Luxembourg | Luxembourg | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.